Veterinary Antibiotics Market, By Drug Type (Aminoglycosides, -Lactam Antibiotics, Chloramphenicol, Fluoroquinolones, Glycopeptides, Lincosamides, Macrolides, Polymixins, Tetracyclines, and Others), By Dosage Form (Powder, Solutions, Injections, and Other

Global veterinary antibiotics market is estimated to be valued at USD 4.18 Bn in 2025 and is expected to exhibit a CAGR of 4.0% during the forecast period (2025-2032). Veterinary antibiotics market has witnessed significant growth due to rising animal healthcare expenditure and increasing prevalence of zoonotic diseases. Growing animal adoption, particularly in developed regions, has also boosted demand for antibiotics to prevent and treat various infections in companion animals. Moreover, changing lifestyles and increasing focus on protein-rich diets from animal sources have revved up meat production across the globe. Large scale livestock production practices necessitate the proper use of antibiotics to promote growth and prevent diseases in animals reared for meat consumption.

Market Dynamics

Rising consumption of livestock-derived food products can drive the veterinary antibiotics market growth. In 2019, according to the United Nations Food and Agriculture Organization, global meat production is projected to grow approximately 15% in the period between 2020 and 2030. However, overuse and misuse of antibiotics in the livestock sector has led to antibiotic resistance, thus, hampering the market growth. Alternative treatment options including bacteriophages and probiotics present significant opportunities for market players. Growing veterinary healthcare infrastructure in developing nations can create new avenues for antibiotics manufacturers in the near future.

Key features of the study

• This report provides in-depth analysis of the global veterinary antibiotics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global veterinary antibiotics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Merck & Co., Inc., Ceva Santé Animale, Zoetis, Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals, Elanco Animal Health Incorporated, Virbac S.A., Bimeda, Inc., Vetoquinol, Zydus Animal Health, Blacksmith Medicines, Inovet, Calier, and Phibro Animal Health Corporation
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global veterinary antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary antibiotics market

• By Drug Type Insights (Revenue, USD Bn, 2019 - 2032)
• Aminoglycosides
• ß-Lactam Antibiotics
• Chloramphenicol
• Fluoroquinolones
• Glycopeptides
• Lincosamides
• Macrolides
• Polymixins
• Tetracyclines
• Others
• By Dosage Form Insights (Revenue, USD Bn, 2019 - 2032)
• Powder
• Solutions
• Injections
• Others
• By Animal Type Insights (Revenue, USD Bn, 2019 - 2032)
• Companion
• Canine
• Feline
• Livestock
• Bovine
• Ovine
• Porcine
• Others (Poultry, etc.)
• Regional Insights (Revenue, USD Bn, 2019 - 2032)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Merck & Co., Inc.
• Ceva Santé Animale
• Zoetis
• Boehringer Ingelheim International GmbH
• Dechra Pharmaceuticals
• Elanco Animal Health Incorporated
• Virbac S.A.
• Bimeda, Inc.
• Vetoquinol
• Zydus Animal Health
• Blacksmith Medicines
• Inovet
• Calier
• Phibro Animal Health Corporation